India to United States: Saxagliptin Export Trade Route
India has recorded 42 verified shipments of Saxagliptin exported to United States, representing a combined trade value of $3.6M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $86.4K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 99% of total export value with 40 shipments worth $3.6M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $2.5M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Saxagliptin corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $3.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's saxagliptin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $86.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with saxagliptin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #17 among India's top saxagliptin export destinations globally.
On the import side, key buyers of Indian saxagliptin in United States include MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC and 2 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 17 shipments valued at $2.5M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#17
- Annual growth+29.2%
- Demand growth+26.3%
- Regulatory ease71/100
Top 10 Indian Saxagliptin Exporters to United States
Showing top 10 of 2 Indian suppliers exporting Saxagliptin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $89.5K per shipment | 40 | $3.6M | 98.8% |
| 2 | GLENMARK PHARMACEUTICALS LTD Avg $22.6K per shipment | 2 | $45.2K | 1.2% |
This table shows the top 10 of 2 Indian companies exporting saxagliptin to United States, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LTD. MYLAN LABORATORIES LIMITED is the dominant supplier with 40 shipments worth $3.6M USD, giving it a 99% market share.
Top 10 Saxagliptin Importers in United States
Showing top 10 of 5 known buyers in United States receiving Saxagliptin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian saxagliptin in United States include MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC, MYLAN PHARMACEUTICALS INC,., DAVID W. PRESSIER. The largest importer is MYLAN PHARMACEUTICALS INC,, accounting for $2.5M USD across 17 shipments — representing 69% of all saxagliptin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC, | 17 | $2.5M | 68.9% |
| 2 | MYLAN PHARMACEUTICALS INC | 17 | $1.1M | 29.1% |
| 3 | GLENMARK PHARMACEUTICALS INC | 2 | $45.2K | 1.2% |
| 4 | MYLAN PHARMACEUTICALS INC,. | 3 | $25.7K | 0.7% |
| 5 | DAVID W. PRESSIER | 3 | $1.3K | 0.0% |
Top 10 Saxagliptin Formulations Imported by United States
Showing top 10 of 29 product formulations shipped on the India to United States Saxagliptin route, ranked by trade value
United States imports a wide range of saxagliptin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SAXAGLIPTIN TAB 5MG 30BT US MY, Packs : — accounts for $530.9K USD across 1 shipments. There are 29 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SAXAGLIPTIN TAB 5MG 30BT US MY, Packs : | 1 | $530.9K | 14.6% |
| 2 | SAXAGLIPTIN TAB 2.5MG 30BT US MY, Packs: | 1 | $291.4K | 8.0% |
| 3 | SAXAGLIPTIN TAB 5MG 30BT US MY PACKS 21067 | 1 | $269.1K | 7.4% |
| 4 | HARMLESS MEDICINES SAXAGLIPTIN TABLETS5 MG 90BT 5280 PACKS | 1 | $228.2K | 6.3% |
| 5 | SAXAGLIPTIN TAB 5MG 30BT US MY Packs : 30'S BOTTLE (16932 PACKS) | 1 | $216.5K | 6.0% |
| 6 | SAXAGLIPTIN TAB5MG30BTUSMY, Packs: 30'S BOTTLE (16440 PACKS) | 1 | $215.2K | 5.9% |
| 7 | SAXAGLIPTIN TAB 5MG 90BT US MY Packs : 90'S BOTTLE (5616 PACKS) | 1 | $212.0K | 5.8% |
| 8 | SAXAGLIPTIN AND METFORMIN HCL EXTENDED-R | 2 | $195.9K | 5.4% |
| 9 | SAXAGLIPTIN TAB 5MG 90BT US MY PACKS 4800 | 1 | $195.0K | 5.4% |
| 10 | SAXAGLIPTIN TAB 5MG 90BT US MY PACKS 4068 | 1 | $153.4K | 4.2% |
Showing top 10 of 29 Saxagliptin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 19 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's saxagliptin exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 40 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $86.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as saxagliptin tab 2.5mg 30bt us my, packs: and saxagliptin tab 5mg 30bt us my packs 21067, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 17 shipments worth $2.5M USD — representing 69% of all saxagliptin imports from India on this route.
Route Statistics
- Trade Volume
- $3.6M
- Avg. Shipment
- $86.4K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~24 days
- Annual Growth
- +29.2%
Related Analysis
Reverse Direction
United States → India — Saxagliptin (Import)Other Saxagliptin Routes
Unlock the Full India to United States Saxagliptin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 42 shipments on this route.
Frequently Asked Questions — India to United States Saxagliptin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Saxagliptin to United States?
The leading Indian exporters of Saxagliptin to United States are MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LTD. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Saxagliptin exports from India to United States?
India exports Saxagliptin to United States worth approximately $3.6M USD across 42 recorded shipments. The average value per shipment is $86.4K USD.
Q Which ports does India use to ship Saxagliptin to United States?
The most active port of origin is SAHAR AIR with 19 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 18% by air.
Q How long does shipping take from India to United States for Saxagliptin?
The average transit time for Saxagliptin shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Saxagliptin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.2% with demand growth tracking at 26.3%. The route is ranked #17 among India's top Saxagliptin export destinations globally.
Q How many suppliers are active on the India to United States Saxagliptin route?
There are currently 2 active Indian suppliers exporting Saxagliptin to United States. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Saxagliptin from India in United States?
The leading importers of Indian Saxagliptin in United States include MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, GLENMARK PHARMACEUTICALS INC, MYLAN PHARMACEUTICALS INC,., DAVID W. PRESSIER. MYLAN PHARMACEUTICALS INC, is the largest buyer with 17 shipments worth $2.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Saxagliptin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 42 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
42 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists